PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Hexylresorcinol→

Hexylresorcinol PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
136-77-6
Molecular formula
C12H18O2
Molecular weight
194.27 g/mol
Drug class
Topical antiseptic and local anaestheticphenolic throat-preparation agent
Mechanism of action
Hexylresorcinol has local anaesthetic activity, likely through blockade of voltage-gated neuronal sodium channels, reducing initiation and conduction of pain impulses in the treated mucosa. It also has mild antiseptic activity against oropharyngeal microorganisms.
Indications / reported uses
  • Temporary relief of sore throat and associated pain in authorised lozenge formulations.
  • Topical antiseptic use in selected skin preparations and products where authorised.

Sources: https://www.medicines.org.uk/emc/product/2701/smpc · https://www.medicines.org.uk/emc/product/5601/smpc · https://pubchem.ncbi.nlm.nih.gov/compound/3610 · https://pmc.ncbi.nlm.nih.gov/articles/PMC7041292/ · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Hexylresorcinol PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Hexylresorcinol Permitted Daily Exposure (PDE) report (the Hexylresorcinol PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Hexylresorcinol Occupational Exposure Limit (OEL) report (the Hexylresorcinol OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.